Testosterone News and Research

Latest Testosterone News and Research

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in The Journal of Urology, an Official Journal of the American Urological Association.

11 Jan 2023

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Researchers evaluated whether insulin-like peptide 3 (INSL3) could predict hypogonadism and age-associated morbidity in older males.

3 Jan 2023

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease – from its beginning to the point of androgen independence, where the tumour no longer responds to hormone deprivation therapy.

14 Dec 2022

New drug candidates for male birth control may be on the horizon

For decades, researchers have been working on "male birth control" - and studies show there is a demand.

30 Nov 2022

Single drug compound may offer a promising new strategy for treating prostate cancer patients

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

23 Nov 2022

Treating long covid is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he'd like.

22 Nov 2022

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Osteoporosis is a major, worsening public health problem and bisphosphonates which help restore a healthier balance of bone production and resorption, have been a relatively inexpensive, successful treatment, particularly for those at highest risk for fractures.

16 Nov 2022

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

For patients with solitary metastases from prostate cancer, an approach called metastasis-directed therapy (MDT) – focused treatment using surgery or radiation therapy, without androgen deprivation therapy (ADT) – can slow the time to cancer progression, reports a study in The Journal of Urology, an Official Journal of the American Urological Association

10 Nov 2022

More babies, lower risk of endometrial cancer

While many highly industrialized and developed countries report falling or negative population growth rates due to a rapid decrease in the number of babies born each year, a new report adds more strength to the evidence that bearing a baby has a protective effect on the endometrium, the lining of the womb, reducing the risk of endometrial cancer.

8 Nov 2022

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood.

8 Nov 2022

Hormone plays vital role in early prediction of age-related morbidity in men

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Novel biomarker for the prediction of age-linked disease

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Post-‘Roe,’ contraceptive failures carry bigger stakes

Birth control options have improved over the decades. Oral contraceptives are now safer, with fewer side effects. Intrauterine devices can prevent pregnancy 99.6% of the time. But no prescription drug or medical device works flawlessly, and people's use of contraception is inexact.

7 Nov 2022

Researchers identify new therapeutic approach against treatment-resistant prostate cancer

Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.

2 Nov 2022

Researchers use AI to predict compounds that could neutralize baldness

Hair loss is undesirable for many men - and women - because one's hairstyle is often closely tied to their self-confidence.

31 Oct 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

$38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical.

26 Oct 2022

Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free survival (PFS) in patients with oligometastatic prostate cancer.

25 Oct 2022

New evidence on how intermittent fasting impacts women's reproductive hormones

Intermittent fasting has been shown to be an effective way to lose weight, but critics have worried that the practice may have a negative impact on women's reproductive hormones.

25 Oct 2022

Study offers a combination treatment option for patients with oligometastatic prostate cancer

A new study offers a new option to patients with oligometastatic prostate cancer who want relief from hormone therapy without compromising the risk of their disease spreading.

25 Oct 2022

Testosterone News and Research

Latest Testosterone News and Research

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

New drug candidates for male birth control may be on the horizon

Single drug compound may offer a promising new strategy for treating prostate cancer patients

Treating long covid is rife with guesswork

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

More babies, lower risk of endometrial cancer

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

Hormone plays vital role in early prediction of age-related morbidity in men

Novel biomarker for the prediction of age-linked disease

Post-‘Roe,’ contraceptive failures carry bigger stakes

Researchers identify new therapeutic approach against treatment-resistant prostate cancer

Researchers use AI to predict compounds that could neutralize baldness

Standard cutoff point for low testosterone levels may not be accurate for young men

$38,398 for a single shot of a very old cancer drug

Combination treatment improves progression-free survival in patients with oligometastatic prostate cancer

New evidence on how intermittent fasting impacts women's reproductive hormones

Study offers a combination treatment option for patients with oligometastatic prostate cancer

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Testosterone News and Research

Latest Testosterone News and Research

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in